Clinical Trial: Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07413263) titled 'Impact of Tyrosine Kinase Inhibitors on Glucose Level and Lipid Metabolism in Chronic Myeloid Leukemia Patients' on Nov. 27, 2025.

Brief Summary: to known the impact of drugs that used in CML pt as TKIs on glucose and lipid metabolism

Study Start Date: May 01, 2026

Study Type: OBSERVATIONAL

Condition: TKIs on CML

Intervention: DRUG: Tyrosine kinase Inhibitors (Imatinib & Nilotinib)

these drugs used in CML only

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Assiut University

Information provided by (Responsible Party): Nancy Atef Abdou Mousa, Assiut University

Disclaimer: Curated by HT Syndication....